Management of Superficial Ulcers/Erosions in Terminal Ileum, Cecum, and Ascending Colon
You should obtain multiple biopsies from the ulcerated areas and surrounding mucosa, test for infectious causes (including stool cultures, C. difficile, and CMV if immunosuppressed), and initiate close follow-up with repeat colonoscopy in 3-4 months if the diagnosis remains uncertain after initial workup.
Initial Diagnostic Approach
The finding of superficial ulcers/erosions in the terminal ileum and right colon requires systematic evaluation to differentiate between inflammatory bowel disease (particularly Crohn's disease), infectious etiologies, drug-induced injury, and idiopathic lesions.
Essential Biopsies and Histology
Multiple biopsies from at least six segments (terminal ileum, ascending, transverse, descending, sigmoid, and rectum) should be obtained, with a minimum of two representative samples from each segment including macroscopically normal segments 1. Target biopsies from the edges of ulcers and aphthous erosions to maximize the possibility of discovering granulomas, which are pathognomonic for Crohn's disease 1. The biopsies should be labeled separately and accompanied by detailed clinical information 1.
Most isolated terminal ileal erosions show nonspecific histopathologic findings (84-92.7% show chronic or active ileitis/inflammation) 2, 3. However, histology is critical to exclude specific diagnoses including tuberculosis, CMV infection, eosinophilic colitis, and malignancy 3.
Infectious Workup
Stool analysis and culture must be performed to exclude infectious colitis, as this accounts for 38% of acute hemorrhagic colitis-type presentations 1. Test for C. difficile toxin in all cases 4.
If the patient is immunosuppressed (on corticosteroids, thiopurines, biologics) or has steroid-resistant disease, CMV testing should be performed via PCR or immunohistochemistry of tissue biopsies 5. CMV colitis is associated with reduced efficacy of therapy and increased colectomy rates 5.
Consider testing for tuberculosis if there is travel history to endemic areas or suggestive clinical features. Colonoscopic findings favoring intestinal tuberculosis include localized involvement, patulous ileocecal valve, transverse ulcers, and scar or pseudopolyp 1.
Medication History
Obtain detailed history of NSAID use, as this is a common cause of isolated colonic ulcers, particularly in the cecum and right colon 6, 7. If NSAIDs are being used, cessation is essential 7.
Cross-Sectional Imaging
MR enterography or intestinal ultrasound should be performed to assess for small bowel disease beyond the reach of colonoscopy and to evaluate for complications 8. Up to 20% of Crohn's disease patients have isolated proximal small bowel disease beyond colonoscopic reach 9, and approximately 36% of patients with normal ileocolonoscopy may have active small bowel disease on cross-sectional imaging 9.
Clinical Course and Follow-Up Strategy
Research evidence provides reassuring data about the natural history of incidental terminal ileal ulcers:
- 44% of asymptomatic patients with terminal ileal ulcers show complete resolution on follow-up colonoscopy, and 28.4% show decreased size or number 2
- The median time to follow-up colonoscopy in these studies was 20 months 2
- However, approximately 29-30% of patients with isolated ileal erosions eventually develop full-blown Crohn's disease, with a mean interval of 3.6 years 6
When to Repeat Colonoscopy
If initial biopsies show nonspecific inflammation and infectious causes are excluded, repeat ileocolonoscopy should be performed in 3-4 months 1. This is particularly important if:
- Symptoms persist or worsen
- The patient has risk factors for IBD (young age, family history)
- Star-shaped ulcers are present (the only endoscopic factor associated with persistence of ulcers) 2
- Initial biopsies showed any chronic inflammatory changes 6
Pathologists should remain diagnostically vigilant when examining repeat ileal biopsies, as persistent mild morphologic abnormalities have a high likelihood of representing Crohn's disease 6.
Treatment Considerations
Conservative Management
If infectious causes are excluded and biopsies show nonspecific inflammation:
- Discontinue NSAIDs if being used 7
- Manage constipation if present 7
- Most idiopathic lesions resolve spontaneously without specific treatment 2, 10
When to Consider IBD Treatment
Do not initiate immunosuppressive therapy until infectious causes (particularly CMV and tuberculosis) are definitively excluded 11.
If Crohn's disease is suspected based on endoscopic features (aphthous ulcers, skip lesions, rectal sparing) and histology supports this diagnosis, treatment should follow standard IBD guidelines. However, 5-aminosalicylic acid should not be used for Crohn's disease as it has no proven efficacy 12.
For mild-to-moderate disease limited to the ileum and ascending colon, budesonide 9 mg daily is recommended for induction of remission 12.
Key Pitfalls to Avoid
- Do not assume all right-sided ulcers are Crohn's disease - infectious causes, NSAID injury, and idiopathic ulcers are common and may resolve spontaneously
- Do not start immunosuppression before excluding infections - this can lead to catastrophic outcomes, particularly with CMV or tuberculosis
- Do not rely solely on initial biopsies - up to 30% of patients with initially nonspecific findings develop Crohn's disease over time 6
- Do not forget to image the small bowel - colonoscopy misses 20% of small bowel Crohn's disease 9
Summary Algorithm
- Obtain comprehensive biopsies (minimum 2 from each of 6 segments) 1
- Test for infections (stool cultures, C. difficile, CMV if immunosuppressed) 1, 5
- Perform MR enterography or intestinal ultrasound 8
- Stop NSAIDs if being used 7
- If diagnosis uncertain and infection excluded: repeat colonoscopy in 3-4 months 1
- If Crohn's disease confirmed: initiate appropriate therapy (budesonide for mild-moderate ileocecal disease) 12
- If idiopathic/nonspecific: conservative management with long-term surveillance given 30% risk of eventual Crohn's disease diagnosis 6